European Archives - Page 466 of 1472 - European Medical Journal

Increased Risk of Digestive Cancers in Celiac Disease

A French study finds significant increases in digestive cancer risks, including small bowel, pancreatic, and gastric cancers, in celiac patients.

HDV Superinfection Risk Persists in People with HBV–HIV Coinfection

A decade-long study has shed light on the risks of hepatitis D virus superinfection in people with HIV co-infected with hepatitis B virus.

Gut Health Boost: Mediterranean Diet Reduces Inflammation in Crohn’s Disease

Adhering to the Mediterranean diet may improve outcomes in newly diagnosed Crohn’s disease by reducing inflammation and promoting a healthier gut microbiome, a new study reveals.

The Role of Social Media in Topical Steroid Withdrawal Awareness

A study leveraging social media platforms explored topical steroid withdrawal among individuals with atopic dermatitis.

male and female symbols

Physicians feel unequipped to address women's health gaps

According to new findings by the HBA and FemTechnology, there are significant systemic challenges and unmet needs in women’s healthcare

Small Heart Size Tied to Increased Mortality in Normal Ejection Fraction Patients

Small heart size increases mortality risk in normal ejection fraction individuals, especially women and high-normal LVEF patients.

Novel Catheter Design Prevents Urethral Strictures After Surgery

The findings demonstrated that the novel drug-injectable urethral catheter set with hyaluronic acid significantly reduced pain and increased patient satisfaction.

New Nomogram Simplifies Diagnosis of Cough Variant Asthma

With traditional bronchial provocation tests often inaccessible in clinical settings, this predictive nomogram offers a practical alternative to assist clinicians.

Point-of-Care Ultrasound Proves Valuable for Diagnosing Retained Products of Conception

POCUS has shown promise as a diagnostic tool for identifying RPOC in women, study finds.

Alzheimer’s Breakthrough: Lecanemab and its Role in Reducing Neurodegeneration

Lecanemab targets toxic amyloid-β protofibrils in Alzheimer’s disease, correlating with reduced neurodegeneration and cognitive decline.